Immunosuppressive treatment of multiple sclerosis.
Multiple sclerosis is one of the most common causes of chronic neurologic disease in adults. Although the exact pathogenesis of multiple sclerosis is unknown, evidence suggests that it is an autoimmune disease. Recent studies have shown a possible significant beneficial effect of cyclophosphamide in the treatment of multiple sclerosis. This article will discuss the rationale of immunosuppressive therapy and identify nursing measures required in such a clinical trial.
Schweitzer
S F
SF
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology / Q000451:nursing; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone